UNC-10245131

N/A

Report date: 2023/03/06 09:58:00
NME

Base Information

Drug NameUNC-10245131
Drug Alias NameUNC-10245131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium and integrin-binding protein 1 inhibitors
TargetsCalcium and integrin-binding protein 1
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina At Chapel Hill
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A